FMC-NA Names Joe Turk New President for Renal Therapies Group
Joseph (Joe) Turk succeeds Mark Constanzo, who recently retired, as the new President for the Fresenius Medical Care North America Renal Therapies Group, and will now oversee the renal products and pharmaceutical operations.
Read the full article » | Posted 08-12-2021
Related Articles
- Baxter Announces Multiple Online Training Videos for Professionals Posted 04-12-2024
- Humana and Strive Health Expand Holistic Partnership to more Humana Members Posted 04-12-2024
- ASN and Home Dialysis University Collaboration to Increase Home Dialysis Posted 04-12-2024
- Telemedicine Can Help Grow Home Dialysis, Reduce Dropout, and Improve Outcomes Posted 03-15-2024